Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787930 · ClinicalTrials.gov registry record
Bipolar Disorder in Late Life
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 19
- Enrollment target
NCT00787930 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 19 participants.
The verdict
NCT00787930 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to look at certain structural changes in the brain in people with bipolar disorder or those with a history of Bipolar disorder.
Interventions
- DRUG Valproic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00787930
The ClinicalTrials.gov registry entry for NCT00787930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valproic Acid is the first listed.
NCT00787930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00787930 about?
NCT00787930 is a clinical study titled "Bipolar Disorder in Late Life". The purpose of this study is to look at certain structural changes in the brain in people with bipolar disorder or those with a history of Bipolar disorder.
What is the current status of trial NCT00787930?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2005-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00787930?
The interventions under investigation include: Valproic Acid (DRUG).
Who is sponsoring clinical trial NCT00787930?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.